Patents by Inventor Francisco Javier CABALLERO CAMINO

Francisco Javier CABALLERO CAMINO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230390308
    Abstract: Compounds derived from ursodeoxycholic acid of formula (I) and to methods for obtaining same, as well as the use thereof in the treatment of polycystic diseases, particularly autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, or autosomal recessive polycystic kidney disease.
    Type: Application
    Filed: July 17, 2023
    Publication date: December 7, 2023
    Inventors: Jesus Maria BANALES ASURMENDI, Luis BUJANDA FERNANDEZ DE PIEROLA, Alvaro SANTOS LASO, Fernando Pedro COSSIO MORA, Ivan RIVILLA DE LA CRUZ, Francisco Javier CABALLERO CAMINO, Manel ESTELLER BADOSA, Jose Juan GARCIA MARIN
  • Patent number: 11833160
    Abstract: The present invention relates to compounds derived from ursodeoxycholic acid of formula (I), to methods for obtaining same, as well as the use thereof in the treatment of polycystic diseases, particularly autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, or autosomal recessive polycystic kidney disease.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: December 5, 2023
    Assignees: UNIVERSIDAD DEL PAIS VASCO/EUSKAL HERRIKO UNIBERTSITATEA, ADMINISTRACIO GENERAL DE LA COMUNIDAD AUTONOMA DE EUSKADI, FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL), UNIVERSIDAD DE SALAMANCA
    Inventors: Jesus Maria Banales Asurmendi, Luis Bujanda Fernandez De Pierola, Alvaro Santos Laso, Fernando Pedro Cossio Mora, Ivan Rivilla De La Cruz, Francisco Javier Caballero Camino, Manel Esteller Badosa, Jose Juan Garcia Marin
  • Publication number: 20210137946
    Abstract: The present invention relates to compounds derived from ursodeoxycholic acid of formula (I), to methods for obtaining same, as well as the use thereof in the treatment of polycystic diseases, particularly autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, or autosomal recessive polycystic kidney disease.
    Type: Application
    Filed: December 28, 2018
    Publication date: May 13, 2021
    Inventors: Jesus Maria BANALES ASURMENDI, Luis BUJANDA FERNANDEZ DE PIEROLA, Alvaro SANTOS LASO, Fernando Pedro COSSIO MORA, Ivan RIVILLA DE LA CRUZ, Francisco Javier CABALLERO CAMINO, Manel ESTELLER BADOSA, Jose Juan GARCIA MARIN